Navigation Links
US and European Computer Aided Detection (CAD) Industry

NEW YORK, July 11, 2013 /PRNewswire/ -- announces that a new market research report is available in its catalogue:

US and European Computer Aided Detection (CAD) Industry

This report analyzes the US and European markets for Computer Aided Detection (CAD) in US$ Million and Number of Units. The report analyzes the US market in Value and Volume terms by the following Application Segments - Breast, and Chest. The European market is analyzed in Value terms by the following Application Segments - Breast, Chest, and Colon. Annual estimates and forecasts are provided for the period 2011 through 2018. The report profiles 28 companies including many key and niche players such as EDDA Technology, Inc., Hologic, Inc., iCAD, Inc., Invivo Corporation, Medipattern Corp., Merge Healthcare Incorporated, Riverain Technologies, Siemens Healthcare, and VuCOMP Inc. Market data and analytics are derived from primary and secondary research. Company profiles are primarily based on public domain information including company URLs.

I. INTRODUCTION, METHODOLOGY & PRODUCT DEFINITIONSStudy Reliability and Reporting Limitations I-1Disclaimers I-2Data Interpretation & Reporting Level I-2Quantitative Techniques & Analytics I-3Product Definitions and Scope of Study I-3II. A US AND EUROPEAN MARKET REPORT


Computer Aided Detection - Offering "Second Look" for

Radiology Analysis II-1

The Need for Early Diagnosis and Role of CAD II-1

Market Highlights II-2

Major Drivers & Restraints II-2

Breast CAD to Hold its Fort in the CAD Market II-3

Economy Slowdown Drubs Market Growth II-3

2. MARKET OVERVIEW & TRENDS II-5From "Second Reader" to "First Reader" Use - the UnconqueredAvenue of CAD Systems II-5CAD Use Rises despite Controversies II-5Replacements to Fuel Market Growth II-6High Dependence on Related Modality Continues II-6Market Calls for Higher Efficiencies in CAD II-6Product Developments Underway to Expand Utility II-6Information Provision - A Key Feature under Development forEnhanced Efficiency II-7Research finds Interactive Use of CAD More Efficient II-8Rising Incidence of Cancer - A Major Market Driver II-8Cancer Prone Sites based on Age II-8World Cancer Statistics - Incidence and Mortality Data II-9Table 1: World Cancer Incidence by Geographic Region andGender (2012): Number of New Cancer Cases Reported inThousands for Asia-Oceania, Europe, North America, LatinAmerica & the Caribbean, and Africa (includes correspondingGraph/Chart) II-9

Table 2: World Cancer Mortality by Geographic Region and

Gender (2012): Number of Cancer-Related Deaths in Thousands

for Asia-Oceania, Europe, North America, Latin America & the

Caribbean, and Africa (includes corresponding Graph/Chart) II-10

Table 3: Global Incidence of Common Cancers in Men (2012):Number of New Cases Reported in Thousands for Lung &Bronchus, Prostate, Colorectal and Liver Cancers (includescorresponding Graph/Chart) II-10

Table 4: Global Incidence of Common Cancers in Women (2012):

Number of New Cases Reported in Thousands for Breast,

Colorectal, Lung & Bronchus and Liver Cancers (includes

corresponding Graph/Chart) II-11

Table 5: Global Cancer Mortality in Men for Select Cancers(2012): Number of Deaths in Thousands for Lung & Bronchus,Liver, Colorectal and Prostate Cancers (includescorresponding Graph/Chart) II-11

Table 6: Global Cancer Mortality in Women for Select Cancers

(2012): Number of Deaths in Thousands for Breast, Lung &

Bronchus, Colorectal and Liver (includes corresponding

Graph/Chart) II-11

Table 7: World Breast Cancer Statistics: Top 20 Countrieswith Highest Breast Cancer Rates (includes correspondingGraph/Chart) II-12


Present Applications of CAD II-13

What Lies Ahead at the Application Front? II-13

CAD in Breast Cancer II-13

CAD Simplifies Breast MRI Image Analysis; Tremendous Scope

for Adoption Ahead II-13

Breast MRI - Lagging behind Mammography in Cancer Detection II-14

CAD Solutions for Breast Cancer II-14

SecondLook Digital CAD (iCAD) II-14

R2 ImageChecker (Hologic, Inc.) II-14

SpectraLook CAD Solution (iCAD) II-14

DynaCAD Breast (Invivo) II-15

CADstream Breast MRI Application (Merge Healthcare) II-15

List of Approved CAD Solutions for Breast MRI II-15

CAD in Prostate Cancer II-16

CAD in Lung Cancer II-16

The Background II-16

An Overview of CAD Solutions for Lung Cancer Detection II-17

IQQA (EDDA Technology) II-17

OnGuard (Riverain Medical) II-17

xLNA (Philips) II-18

syngo CAD Solutions (Siemens) II-18

CAD in Liver Cancer II-18

CAD Solutions for Liver Cancer Detection II-18

CADstream (Merge Healthcare) II-18

IQQA (EDDA Technology) II-18

CAD in the Detection of Prostate Cancer II-19

Available CAD Solutions for Prostate Cancer II-19

CAD in the Detection of Colon Cancer II-19

CAD in Cardiology II-20

Increasing Need for CAD in Cardiology II-20

Automatic Workflow Integration Fuels Demand for Cardiac CAD II-20

Significant Hurdles Exist for CAD in Cardiology II-21

4. COMPETITION II-22Competitive Landscape II-22iCAD - A Leading Independent Player in the Mammography CADSegment II-22Restructuring Likely in CAD Industry II-22


5a. THE UNITED STATES II-24A.Market Analysis II-24Current & Future Analysis II-24CAD to Gain from Rapid Growth in CTC Volumes II-24FDA Approved CAD Software: 1998-2012 II-25Challenges in Evaluation Dents Approvals of New CAD Systems II-27Final Guidance Documents on CAD offers Respite to IndustryPlayers II-27CAD Devices, as Defined by the FDA II-28Guidance on 510(k) Application II-28FDA's FFDM Reclassification to Benefit CAD Market II-28Physicians' Reluctance to Follow USPSTF - A Shot in the Armfor CAD Manufacturers II-28Mammography and Breast MRI, and CAD Reimbursement in the US II-29CMS Coverage for Screening and Diagnostic Mammography andBreast MRI - A Review II-29Table 8: Medicare Reimbursement Codes and Allowable Ratesfor CAD in Mammography: 2011-2013 II-30Low and Spotty Reimbursement Mars CAD in Prostate CancerDetection II-30No Separate Codes for CAD in Prostate MRI II-30Cancer Statistics II-31Rising Incidence of Cancer II-31Table 9: Cancer Incidence in the US by Site for Male andFemale Populations (2013): Breakdown of Number of NewCases for Breast, Lung & Bronchus, Colon, Liver &Intrahepatic Bile Duct, Prostate and Other Cancers(includes corresponding Graph/Chart) II-31

Table 10: Cancer Mortality in the US by Site for Male and

Female Populations (2013): Breakdown of Number of Deaths

for Breast, Lung & Bronchus, Colon & Rectum, Liver &

Intrahepatic Bile Duct, Prostate and Other Cancers

(includes corresponding Graph/Chart) II-32

B.Market Analytics II-33

Table 11: US Recent Past, Current & Future Analysis for

Computer Aided Detection (CAD) by Application - Breast,

Chest and Other CAD Markets Independently Analyzed with

Annual Sales Figures in US$ Million for Years 2011 through

2018 (includes corresponding Graph/Chart) II-33

Table 12: US Historic Review for Computer Aided Detection(CAD) by Application - Breast, Chest and Other CAD MarketsIndependently Analyzed with Annual Sales Figures in US$Million for Years 2007 through 2010 (includes correspondingGraph/Chart) II-34

Table 13: US 12-Year Perspective for Computer Aided

Detection (CAD) by Application - Percentage Breakdown of

Dollar Sales for Breast, Chest and Other CAD Markets for

Years 2007, 2012 and 2018 (includes corresponding

Graph/Chart) II-35

5b. EUROPE II-36A.Market Analysis II-36Current & Future Analysis II-36CAD Market in Europe - An Overview II-36Economic Woes Dampen European CAD Market Prospects II-36Long-Term Prospects Appear Brighter II-37Rising Incidence of Cancer II-37Table 14: European Cancer Incidence by Geographic Region(2012): Number of New Cancer Cases Reported in Thousandsfor Western Europe, Northern Europe, Southern Europe, andCentral & Eastern Europe (includes correspondingGraph/Chart) II-38

Table 15: Cancer Incidence in Western Europe by Site

(2012): Number of New Cancer Cases Reported in Thousands

for Prostate, Breast, Colorectal, Lung and Other Cancers

(includes corresponding Graph/Chart) II-38

Table 16: Cancer Incidence in Northern Europe by Site(2012): Number of New Cancer Cases Reported in Thousandsfor Breast, Prostate, Colorectal, Lung and Other Cancers(includes corresponding Graph/Chart) II-39

Table 17: Cancer Incidence in Southern Europe by Site

(2012): Number of New Cancer Cases Reported in Thousands

for Colorectal, Breast, Lung, Prostate and Other Cancers

(includes corresponding Graph/Chart) II-39

Table 18: Cancer Incidence in Central and Eastern Europe bySite (2012): Number of New Cancer Cases Reported inThousands for Lung, Colorectal, Breast, Stomach and OtherCancers (includes corresponding Graph/Chart) II-39B.Market Analytics II-40Table 19: European Recent Past, Current & Future Analysisfor Computer Aided Detection (CAD) by Application - Breast,Chest and Other CAD Markets Independently Analyzed withAnnual Sales Figures in US$ Million for Years 2011 through2018 (includes corresponding Graph/Chart) II-40

Table 20: European Historic Review for Computer Aided

Detection (CAD) by Application - Breast, Chest and Other CAD

Markets Independently Analyzed with Annual Sales Figures in

US$ Million for Years 2007 through 2010 (includes

corresponding Graph/Chart) II-41

Table 21: European 12-Year Perspective for Computer AidedDetection (CAD) by Application Segment - PercentageBreakdown of Breast, Chest and Other CAD Markets for Years2007, 2012 and 2018 (includes corresponding Graph/Chart) II-42


CAD - An Introduction II-43

A Brief History of CAD II-43

Methodology II-43

Sensitivity / Specificity II-44

Absolute Detection Rate II-44

Applications of Computer-Aided Detection II-44

Breast Cancer: II-44

Lung Cancer (Bronchial Carcinoma): II-44

Evolution of Computer-Aided Detection for Mammography II-44

CAD Technology - Working Operation II-45

Existing Limitations of CAD II-45

7. PRODUCT INNOVATIONS/INTRODUCTIONS II-46iCAD Obtains FDA Clearance for Mammography CAD Platform II-46VuCOMP Receives Premarket Approval from FDA for M-Vu DigitalMammography CAD II-46VuCOMP Receives Premarket Approval from FDA for M-Vu FilmMammography CAD II-46iCAD Introduces Advanced Mammography CAD System II-46Parascript Unveils Updated AccuDetect CAD Technology II-47Parascript Unveils AccuDetect 5.0 Software II-47Confirma® Rolls Out CADstream Prostate Application II-48iCAD Rolls Out SecondLook® Premier CAD Technology II-48iCAD Launches VeraLook CTC CAD Solution with Products of VitalImage II-48Medicsight Obtains FDA 510(k) Approval to Market ColonCAD System II-49iCAD Obtains SFDA Approval in China for SecondLook® DigitalCAD Technology II-49iCAD Introduces New VeraLook CAD Technology Version for CTColonography in Europe II-49Medicsight Launches MedicRead 3.0 Colon II-50Confirma Introduces New Applications for MRI-CAD II-50Medicsight Introduces ColonCAD API 4.0 II-50iCAD Expands SecondLook Digital CAD Technology Market II-50Definiens Launches LymphExpert II-51iCAD to Launch New CAD Solutions II-51Parascript Introduces AccuDetect 2.0 II-51MeVis Unveils MeVis Visia™ CT Lung System II-51Medipattern Introduces New B-CAD Versions II-52Fujifilm Unveils FCR Digital Mammography CAD MV-SR657 II-52iCAD Introduces SecondLook Digital for Sectra's MicroDoseMammography System II-52iCAD Launches TotalLook MammoAdvantage System II-52


Real Time Tomography Inks Licensing Agreement with im3D II-53

iCAD and Invivo Ink Agreement II-53

Planmed and Three Palm Software Ink Partnership Agreement II-53

Sectra Signs Agreement with Merge Healthcare II-54

Medipattern Inks Agreement with TomTec Imaging Systems II-54

INFINITT North America and Medicsight Enter into Marketing

Partnership II-54

iCAD and Carestream Sign Global Distribution Agreement II-55

Medicsight Signs Agreement with Ziosoft II-55

Canon and MEDIAN Technologies Ink Agreement II-56

iCAD Enters into Partnership with Mtakina International II-56

Merge Healthcare Acquires Confirma II-57

Merge Healthcare Expands EU Distribution Agreement with MEDRAD II-57

Alma IT Systems and Medicsight Ink Agreement II-57

Medipattern and LIRA Enter into B-CAD-FOR-LIFE™ Agreement II-57

Definiens and Imaging Service Enter into Partnership II-58

iCAD Purchases CAD Sciences Assets II-58

Medicsight and INFINITT Enter Into Partnership II-58

iCAD® Receives Approval from FDA II-59

Medipattern and iPACS Ink Agreement II-59

Riverain Bags Veterans Affairs CAD Contract II-59

9. FOCUS ON SELECT PLAYERS II-60EDDA Technology, Inc. (US) II-60Hologic, Inc. (US) II-60iCAD, Inc. (US) II-61Invivo Corporation (US) II-63Medipattern Corp. (Canada) II-63Merge Healthcare Incorporated (US) II-64Riverain Technologies (US) II-65Siemens Healthcare (Germany) II-65VuCOMP Inc. (US) II-66III. COMPETITIVE LANDSCAPE

Total Companies Profiled: 28 (including Divisions/Subsidiaries - 30)

The United States (17)Canada (1)Japan (1)Europe (10)- Germany (3)- The United Kingdom (1)- Spain (1)- Rest of Europe (5)Asia-Pacific (Excluding Japan) (1)

To order this report:Pathology Industry: US and European Computer Aided Detection (CAD) Industry

Contact Clare:

US:(339) 368 6001

Intl:+1 339 368 6001

SOURCE Reportlinker
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. EAACI Publishes the First European Guidelines for food-Allergy Sufferers
2. Sorrento Therapeutics and IGDRASOL to Present Late Stage Clinical Data Updates on their Oncology Nanomedicine Platform at the Joint Meeting of the European Foundation for Clinical Nanomedicine and European Technology Platform on Nanomedicine in Base
3. European Orthopedic Market 2017 Forecasts: Hip, Knee & Shoulder Analysis in New Research Report at
4. Surveyed U.S. and European Neurologists Identify Better Seizure-Free Efficacy as One of the Greatest Unmet Needs in Treating Partial-Onset Seizures in Refractory Epilepsy Patients
5. U.S. and European Rheumatologists Agree That a Therapys Induction of Remission is One of the Attributes That Most Influences Their Prescribing Decisions in Rheumatoid Arthritis
6. AbbVie Presents Preliminary Results from Phase I Study of Investigational Oncology Compound ABT-199/GDC-0199 in Patients with High-Risk Chronic Lymphocytic Leukemia (CLL) at European Hematology Association Annual Meeting
7. CTI Announces Data Presentations at the 18th Congress of the European Hematology Association
8. Hospira Data on European Biosimilar Epoetin, Retacrit, Affirm Treatment Response, Tolerability in Management of Anemia Secondary to Chemotherapy
9. Oramed Selected to Present at the 81st European Atherosclerosis Society Congress in Lyon, France, June 2-5, 2013
10. Cardica Completes Enrollment In European Clinical Trial For Surgical Cutting And Stapling Device
11. Life Care Medical Devices Ltd Announces Addition Of Dublin, Ireland Based European Subsidiary
Post Your Comments:
(Date:3/28/2017)... 2017 The global emerging cancer diagnostics market ... from 2016 to 2023 and reach a figure of ... is a chronic disease and is affecting a huge ... market. This report is focused on emerging cancer diagnostics ... is propelled due to factors such as: increasing number ...
(Date:3/28/2017)... 2017  Medeon Biodesign, Inc., a ... to announce that the Company led and successfully ... Inc., a San Jose, CA ... orthopedic extremity applications.  The orthopedic ... due to procedure volume growth, lifestyle influences and ...
(Date:3/28/2017)... -- "US Cancer Generics Market Outlook 2022" report gives ... analysis related to the emergence and integration of ... US. The report analyzes various clinical and non-clinical ... drugs in recent years. The introduction of generics ... for various stake holders involved US cancer drug ...
Breaking Medicine Technology:
(Date:3/28/2017)... ... March 28, 2017 , ... ... the first technology to directly address the resolution to globally reduce the harmful ... a patented compound of FDA and TTB approved ingredients that when infused into ...
(Date:3/28/2017)... ... March 28, 2017 , ... Resoundant, Inc., the developer of ... Siemens Healthineers annual customer education symposium, a world-class learning conference that offers educational ... 27 - 31, 2017 at the Atlanta Marriott Marquis in Atlanta, Georgia. , ...
(Date:3/28/2017)... ... March 29, 2017 , ... The Thyroid Secret is a ... FASCP. The program was recently launched on March 1, and Dr. Wentz discussed ... , Dr. Izabella Wentz is a licensed pharmacist and a foremost thyroid ...
(Date:3/28/2017)... Seattle, WA (PRWEB) , ... March 28, 2017 ... ... reach a 22% share of all holidays (IBT World Travel Trends Report). As ... physically challenging, include a range in temperatures, and prolonged sun exposure. In response, ...
(Date:3/28/2017)... ... March 28, 2017 , ... ... advancing the science and clinical practice of radiosurgery, announced today the publication ... multi-institutional, observational registry established to standardize data collection from patients treated with ...
Breaking Medicine News(10 mins):